Search

Your search keyword '"Clavelou, Pierre"' showing total 542 results

Search Constraints

Start Over You searched for: Author "Clavelou, Pierre" Remove constraint Author: "Clavelou, Pierre"
542 results on '"Clavelou, Pierre"'

Search Results

5. Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal

6. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

7. Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.

8. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022

9. Comparison of 2 Methods for Estimating Multiple Sclerosis–Related Mortality

11. Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.

14. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

17. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

18. High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

19. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

20. Impact of reference panel composition on scores of script concordance test assessing basic nephrology knowledge in undergraduate medical education.

21. Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis

22. Impact of reference panel composition on scores of script concordance test assessing basic nephrology knowledge in undergraduate medical education

23. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

24. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

27. Prospective validation of the PML risk biomarker L-Selectin and influence of natalizumab extended intervals

29. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study

30. The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus

32. Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

33. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

35. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial

37. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

38. Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: Neurophysiological data and proposed electrodiagnostic criteria

40. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.

43. Multi-center, Randomized, Double-blinded Assessment of TERIFLUNOMIDE (Aubagio®) in Extending the Time to the First Attack in Radiologically Isolated Syndrome: Baseline Characteristics of the TERIS Study. (P5-4.011)

44. Prospective Characterization of Brain T2 Lesions Suggestive of Demyelination in Asymptomatic Patients diagnosed as Radiologically Isolated Syndrome (P14-4.011)

45. The Use of a Fixed 50:50 Mixture of Nitrous Oxide and Oxygen to Reduce Lumbar Puncture-Induced Pain in the Emergency Department: A Randomized Controlled Trial

46. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

48. CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments

Catalog

Books, media, physical & digital resources